Nebivolol does not protect against 5/6 ablation/infarction induced chronic kidney disease in rats - comparison with angiotensin II receptor blockade
about
Molecular mechanisms of neuronal nitric oxide synthase in cardiac function and pathophysiologyCardiac function and tolerance to ischemia-reperfusion injury in chronic kidney diseaseCardiac function is preserved following 4 weeks of voluntary wheel running in a rodent model of chronic kidney diseaseAntihypertensive and renoprotective actions of soluble epoxide hydrolase inhibition in ANG II-dependent malignant hypertension are abolished by pretreatment with L-NAME.The role played by oxidative stress in evoking the exercise pressor reflex in health and simulated peripheral artery disease.
P2860
Nebivolol does not protect against 5/6 ablation/infarction induced chronic kidney disease in rats - comparison with angiotensin II receptor blockade
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Nebivolol does not protect aga ...... giotensin II receptor blockade
@ast
Nebivolol does not protect aga ...... giotensin II receptor blockade
@en
type
label
Nebivolol does not protect aga ...... giotensin II receptor blockade
@ast
Nebivolol does not protect aga ...... giotensin II receptor blockade
@en
prefLabel
Nebivolol does not protect aga ...... giotensin II receptor blockade
@ast
Nebivolol does not protect aga ...... giotensin II receptor blockade
@en
P2093
P2860
P1433
P1476
Nebivolol does not protect aga ...... giotensin II receptor blockade
@en
P2093
Chris Baylis
Natasha C Moningka
Tatsiana Tsarova
P2860
P356
10.1016/J.LFS.2012.06.005
P407
P577
2012-06-19T00:00:00Z